Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment.
This study examines the role of uraemia and the effect of different dialysis treatments on red cell cation transport. We evaluated the main cation transport systems in erythrocytes of non-dialysed end-stage renal disease (ESRD) subjects, of patients undergoing haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), as well as the changes induced by human recombinant erythropoietin (r-HuEPO) administration. In uraemic undialysed and dialysed patients, we observed an increase in K/Cl co-transport activity and in shrinkage-induced amiloride-sensitive (HMA-sensitive) Na efflux (Na/H exchange) and a decrease in Na/K pump and Na/K/Cl co-transport activity, while Na/Li exchange was increased only in dialysed patients. In uraemic erythrocytes, we showed for the first time an increased K/Cl co-transport activity, which was cell age independent. Generally, the different method of dialysis (CAPD or HD) did not modify the cation transport abnormalities observed. During the treatment with r-HuEPO, all the systems, with the exception of the Na/K pump and Na/K/Cl co-transport, increased their activities following the increase of circulating young red cells. The changes produced under r-HuEPO administration were transient and cation transports returned to the baseline values within 100 days of treatment, indicating a primary and prominent pathogenetic role of uraemia in modulating the red cell membrane cation transport activities.
De Franceschi
L
L
Department of Internal Medicine, University of Verona, Italy.
Olivieri
O
O
Girelli
D
D
Lupo
A
A
Bernich
P
P
Corrocher
R
R
D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D002712:Chlorides / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D017136:Ion Transport; D007676:Kidney Failure, Chronic / Q000150:complications; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011188:Potassium / Q000378:metabolism*; D006435:Renal Dialysis; D017582:Renal Replacement Therapy; D012964:Sodium / Q000378:metabolism*; D014511:Uremia / Q000097:blood* / Q000209:etiology / Q000628:therapy
D002712:Chlorides; D004921:Erythropoietin; D012964:Sodium; D011188:Potassium